Tecovirimat CAS NO.816458-31-8

Chemvon Biotechnology is one of the leading high-technology manufacturer in the field of pharmaceutical and fine chemical industry.

From origins as a research group in technology service, chemvon has progressed into an integrated company with a kilo lab and a pilot plant offering a range of APIs, NCEs and some organic intermediates.

Quality: Adopting the leading technology to assure the high quality.

Price: Offering the best price among the suppliers in China.

Rich material and energe make us control the cost effective

Afrer-sale service: Chemvon will take charge of everthing if there is any question after the sale.

Certificates: We can offer ISO9001 certificates that you need for importing.

Tecovirimat (ST-246) is an antiviral with activity against orthopoxviruses such as smallpox and is currently undergoing clinical trials. It was previously owned by Viropharma and discovered in collaboration with scientists at USAMRIID. It is currently owned and is synthesized by SIGA Technologies, a drug development company in the biodefense arena. It works by blocking cellular transmission of the virus, thus preventing the disease. Tecovirimat has been effective in laboratory testing, with no serious side effects reported to date.